{
    "eid": "2-s2.0-85169024281",
    "title": "Efficiency Comparative Approach of Plant-Produced Monoclonal Antibodies against Rabies Virus Infection",
    "cover-date": "2023-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "monoclonal antibody",
        "Nicotiana benthamiana",
        "plant produced antibody cocktail",
        "post-exposure prophylaxis",
        "rabies virus"
    ],
    "authors": [
        "Boonlert Lumlertdacha",
        "Bancha Mahong",
        "Kaewta Rattanapisit",
        "Christine Joy I. Bulaon",
        "Thiravat Hemachudha",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 0,
    "ref-count": 33,
    "ref-list": [
        "Rabies re-examined",
        "Human rabies: A disease of complex neuropathogenetic mechanisms and diagnostic challenges",
        "Human rabies prevention--United States, 2008: Recommendations of the Advisory Committee on Immunization Practices",
        "Rabies",
        "Equine rabies immunoglobulin: A study on its clinical safety",
        "Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans",
        "Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans",
        "Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies",
        "A rabies-specific human monoclonal antibody that protects mice against lethal rabies",
        "Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis",
        "Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies",
        "Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody",
        "Passive immunity in the prevention of rabies",
        "Design of future rabies biologics and antiviral drugs",
        "Molecular Pharming: Future targets and aspirations",
        "Function and glycosylation of plant-derived antiviral monoclonal antibody",
        "Monoclonal antibodies for prophylactic and therapeutic use against viral infections",
        "First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity",
        "Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine",
        "Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3",
        "Transmission dynamics of rabies virus in Thailand: Implications for disease control",
        "Functional Characterization of Pembrolizumab Produced in Nicotiana benthamiana Using a Rapid Transient Expression System",
        "A rapid reproducible test for determining rabies neutralizing antibody",
        "Dose translation from animal to human studies revisited",
        "Conservation of binding epitopes for monoclonal antibodies on the rabies virus glycoprotein",
        "Monoclonal antibodies for rabies post-exposure prophylaxis: A paradigm shift in passive immunization",
        "Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: A review of the current status of the clinical development pipeline",
        "Techno-economic analysis of a transient plant-based platform for monoclonal antibody production"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015572",
            "affilname": "Thailand Government Pharmaceutical Organization",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015572",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Government Pharmaceutical Organization Thailand"
    ]
}